| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.979 | 0.001 | 0.979 | Bile acid receptor antagonist | 0.954 0.001 DBMET03598 0.845 0.001 DBMET03599 0.979 0.001 DB06777 | ||
| 0.961 | 0.001 | 0.961 | Cholesterol antagonist | 0.957 0.001 DBMET03598 0.957 0.001 DBMET03599 0.961 0.001 DB06777 | ||
| 0.941 | 0.001 | 0.941 | Phospholipase C inhibitor | 0.924 0.001 DBMET03598 0.862 0.002 DBMET03599 0.941 0.001 DB06777 | ||
| 0.898 | 0.001 | 0.898 | Sodium/bile acid cotransporter inhibitor | 0.701 0.001 DBMET03598 0.643 0.001 DBMET03599 0.898 0.001 DB06777 | ||
| 0.876 | 0.004 | 0.88 | Caspase 9 stimulant | 0.88 0.004 DBMET03598 0.875 0.004 DBMET03599 0.876 0.004 DB06777 | DBMET03598 | |
| 0.845 | 0.002 | 0.912 | Anesthetic general | 0.912 0.001 DBMET03598 0.912 0.001 DBMET03599 0.845 0.002 DB06777 | DBMET03599 | |
| 0.847 | 0.01 | 0.847 | Antiinflammatory | 0.819 0.013 DBMET03598 0.813 0.014 DBMET03599 0.847 0.01 DB06777 | ||
| 0.79 | 0.007 | 0.79 | Cyclophilin D inhibitor | 0.757 0.009 DBMET03598 0.704 0.014 DBMET03599 0.79 0.007 DB06777 | ||
| 0.754 | 0.001 | 0.754 | Cholesterol synthesis inhibitor | 0.743 0.001 DBMET03598 0.735 0.001 DBMET03599 0.754 0.001 DB06777 | ||
| 0.772 | 0.02 | 0.772 | Apoptosis agonist | 0.764 0.021 DBMET03598 0.757 0.022 DBMET03599 0.772 0.02 DB06777 | ||
| 0.758 | 0.016 | 0.758 | Transcription factor NF kappa B inhibitor | 0.727 0.018 DBMET03598 0.73 0.018 DBMET03599 0.758 0.016 DB06777 | ||
| 0.71 | 0.004 | 0.71 | Apoptosis antagonist | 0.675 0.005 DBMET03598 0.625 0.007 DBMET03599 0.71 0.004 DB06777 | ||
| 0.701 | 0.011 | 0.701 | Antiobesity | 0.631 0.017 DBMET03598 0.588 0.022 DBMET03599 0.701 0.011 DB06777 | ||
| 0.672 | 0.005 | 0.672 | Hypolipemic | 0.648 0.005 DBMET03598 0.579 0.008 DBMET03599 0.672 0.005 DB06777 | ||
| 0.662 | 0.001 | 0.662 | Farnesoid X receptor agonist | 0.525 0.001 DBMET03598 0.438 0.001 DBMET03599 0.662 0.001 DB06777 | ||
| 0.656 | 0.001 | 0.767 | 5-Alpha-reductase inhibitor | 0.642 0.001 DBMET03598 0.767 0.001 DBMET03599 0.656 0.001 DB06777 | DBMET03599 | |
| 0.633 | 0.002 | 0.633 | Lipocortins synthesis antagonist | 0.584 0.002 DBMET03598 0.55 0.003 DBMET03599 0.633 0.002 DB06777 | ||
| 0.627 | 0.004 | 0.627 | Hepatoprotectant | 0.567 0.005 DBMET03598 0.589 0.005 DBMET03599 0.627 0.004 DB06777 | ||
| 0.612 | 0.012 | 0.612 | Immunosuppressant | 0.603 0.013 DBMET03598 0.594 0.014 DBMET03599 0.612 0.012 DB06777 | ||
| 0.593 | 0.007 | 0.593 | Angiogenesis stimulant | 0.535 0.01 DBMET03598 0.447 0.016 DBMET03599 0.593 0.007 DB06777 | ||
| 0.567 | 0.002 | 0.749 | Pregnane X receptor agonist | 0.749 0.002 DBMET03598 0.745 0.002 DBMET03599 0.567 0.002 DB06777 | DBMET03598 | |
| 0.555 | 0.004 | 0.579 | Interferon gamma antagonist | 0.564 0.003 DBMET03598 0.579 0.003 DBMET03599 0.555 0.004 DB06777 | DBMET03599 | |
| 0.553 | 0.003 | 0.62 | Androgen antagonist | 0.529 0.004 DBMET03598 0.62 0.003 DBMET03599 0.553 0.003 DB06777 | DBMET03599 | |
| 0.552 | 0.005 | 0.672 | Diuretic | 0.62 0.004 DBMET03598 0.672 0.004 DBMET03599 0.552 0.005 DB06777 | DBMET03599 | |
| 0.538 | 0.002 | 0.538 | Farnesoid X receptor antagonist | 0.484 0.003 DBMET03598 0.442 0.003 DBMET03599 0.538 0.002 DB06777 | ||
| 0.541 | 0.007 | 0.637 | Interleukin agonist | 0.637 0.004 DBMET03598 0.513 0.008 DBMET03599 0.541 0.007 DB06777 | DBMET03598 | |
| 0.555 | 0.022 | 0.555 | Immunostimulant | 0.544 0.023 DBMET03598 0.485 0.031 DBMET03599 0.555 0.022 DB06777 | ||
| 0.54 | 0.031 | 0.579 | Antibacterial | 0.491 0.043 DBMET03598 0.579 0.023 DBMET03599 0.54 0.031 DB06777 | DBMET03599 | |
| 0.522 | 0.014 | 0.522 | Nitric oxide antagonist | 0.497 0.016 DBMET03598 0.504 0.015 DBMET03599 0.522 0.014 DB06777 | ||
| 0.505 | 0.013 | 0.505 | DNA damaging | 0.48 0.016 DBMET03598 0.363 0.037 DBMET03599 0.505 0.013 DB06777 | ||
| 0.494 | 0.004 | 0.494 | Expectorant | 0.377 0.005 DBMET03598 0.306 0.008 DBMET03599 0.494 0.004 DB06777 | ||
| 0.454 | 0.001 | 0.585 | 5-Alpha-reductase 2 inhibitor | 0.585 0.001 DBMET03598 0.516 0.001 DBMET03599 0.454 0.001 DB06777 | DBMET03598 | |
| 0.484 | 0.031 | 0.484 | Antithrombotic | 0.475 0.033 DBMET03598 0.386 0.053 DBMET03599 0.484 0.031 DB06777 | ||
| 0.468 | 0.028 | 0.483 | Immunomodulator | 0.483 0.026 DBMET03598 0.363 0.056 DBMET03599 0.468 0.028 DB06777 | DBMET03598 | |
| 0.458 | 0.019 | 0.458 | Hypoxia-inducible factor 1 alpha inhibitor | 0.411 0.027 DBMET03598 0.355 0.043 DBMET03599 0.458 0.019 DB06777 | ||
| 0.431 | 0.001 | 0.534 | 5-Alpha-reductase 1 inhibitor | 0.534 0.001 DBMET03598 0.482 0.001 DBMET03599 0.431 0.001 DB06777 | DBMET03598 | |
| 0.441 | 0.017 | 0.476 | Interleukin 2 agonist | 0.476 0.011 DBMET03598 0.428 0.02 DBMET03599 0.441 0.017 DB06777 | DBMET03598 | |
| 0.419 | 0.005 | 0.458 | DNA polymerase I inhibitor | 0.458 0.005 DBMET03598 0.396 0.006 DBMET03599 0.419 0.005 DB06777 | DBMET03598 | |
| 0.414 | 0.007 | 0.414 | Protein kinase stimulant | 0.4 0.008 DBMET03598 0.407 0.008 DBMET03599 0.414 0.007 DB06777 | ||
| 0.413 | 0.007 | 0.413 | Alkylator | 0.386 0.008 DBMET03598 0.247 0.017 DBMET03599 0.413 0.007 DB06777 | ||
| 0.409 | 0.006 | 0.409 | Antipruritic | 0.368 0.008 DBMET03598 0.293 0.015 DBMET03599 0.409 0.006 DB06777 | ||
| 0.419 | 0.025 | 0.428 | Hypoglycemic | 0.428 0.023 DBMET03598 0.387 0.03 DBMET03599 0.419 0.025 DB06777 | DBMET03598 | |
| 0.399 | 0.006 | 0.399 | Insulin secretagoues | 0.313 0.011 DBMET03598 0.222 0.027 DBMET03599 0.399 0.006 DB06777 | ||
| 0.423 | 0.038 | 0.433 | Caspase 3 stimulant | 0.433 0.034 DBMET03598 0.412 0.041 DBMET03599 0.423 0.038 DB06777 | DBMET03598 | |
| 0.388 | 0.003 | 0.388 | Mucolytic | 0.301 0.004 DBMET03598 0.251 0.006 DBMET03599 0.388 0.003 DB06777 | ||
| 0.384 | 0.003 | 0.403 | CDC25A inhibitor | 0.403 0.003 DBMET03598 0.352 0.003 DBMET03599 0.384 0.003 DB06777 | DBMET03598 | |
| 0.413 | 0.033 | 0.413 | Antioxidant | 0.397 0.035 DBMET03598 0.388 0.037 DBMET03599 0.413 0.033 DB06777 | ||
| 0.386 | 0.03 | 0.386 | Platelet antagonist | 0.386 0.03 DBMET03598 0.298 0.053 DBMET03599 0.386 0.03 DB06777 | ||
| 0.363 | 0.008 | 0.465 | Neurotrophic factor enhancer | 0.465 0.004 DBMET03598 0.412 0.005 DBMET03599 0.363 0.008 DB06777 | DBMET03598 | |
| 0.348 | 0.003 | 0.412 | Androgen agonist | 0.403 0.002 DBMET03598 0.412 0.002 DBMET03599 0.348 0.003 DB06777 | DBMET03599 | |
| 0.351 | 0.008 | 0.357 | Growth factor agonist | 0.357 0.008 DBMET03598 0.311 0.013 DBMET03599 0.351 0.008 DB06777 | DBMET03598 | |
| 0.374 | 0.036 | 0.401 | Calcium channel activator | 0.401 0.024 DBMET03598 0.398 0.025 DBMET03599 0.374 0.036 DB06777 | DBMET03598 | |
| 0.338 | 0.001 | 0.351 | Arachidonic acid antagonist | 0.345 0.001 DBMET03598 0.351 0.001 DBMET03599 0.338 0.001 DB06777 | DBMET03599 | |
| 0.355 | 0.019 | 0.363 | Platelet adhesion inhibitor | 0.363 0.017 DBMET03598 0.331 0.024 DBMET03599 0.355 0.019 DB06777 | DBMET03598 | |
| 0.355 | 0.02 | 0.355 | P-glycoprotein inhibitor | 0.311 0.027 DBMET03598 0.29 0.031 DBMET03599 0.355 0.02 DB06777 | ||
| 0.324 | 0.005 | 0.324 | ABCA1 expression enhancer | 0.319 0.005 DBMET03598 0.258 0.005 DBMET03599 0.324 0.005 DB06777 | ||
| 0.313 | 0.005 | 0.313 | AMP-activated protein kinase stimulant | 0.277 0.005 DBMET03598 0.157 0.024 DBMET03599 0.313 0.005 DB06777 | ||
| 0.325 | 0.028 | 0.325 | Growth hormone agonist | 0.231 0.048 DBMET03598 0.206 0.056 DBMET03599 0.325 0.028 DB06777 | ||
| 0.305 | 0.01 | 0.305 | Protein-tyrosine phosphatase 1B inhibitor | 0.294 0.011 DBMET03598 0.258 0.015 DBMET03599 0.305 0.01 DB06777 | ||
| 0.317 | 0.023 | 0.317 | Gastrin inhibitor | 0.307 0.028 DBMET03598 0.269 0.058 DBMET03599 0.317 0.023 DB06777 | ||
| 0.292 | 0.003 | 0.292 | Liver X receptor alpha agonist | 0.271 0.003 DBMET03598 0.095 0.005 DBMET03599 0.292 0.003 DB06777 | ||
| 0.291 | 0.002 | 0.347 | Glycine receptor agonist | 0.347 0.002 DBMET03598 0.251 0.003 DBMET03599 0.291 0.002 DB06777 | DBMET03598 | |
| 0.358 | 0.07 | 0.358 | Vasodilator, peripheral | 0.331 0.082 DBMET03598 0.223 0.151 DBMET03599 0.358 0.07 DB06777 | ||
| 0.302 | 0.019 | 0.302 | Protein-tyrosine phosphatase inhibitor | 0.296 0.02 DBMET03598 0.268 0.026 DBMET03599 0.302 0.019 DB06777 | ||
| 0.295 | 0.012 | 0.415 | Aldehyde dehydrogenase inhibitor | 0.415 0.005 DBMET03598 0.283 0.013 DBMET03599 0.295 0.012 DB06777 | DBMET03598 | |
| 0.306 | 0.03 | 0.383 | RNA-directed DNA polymerase inhibitor | 0.383 0.02 DBMET03598 0.281 0.036 DBMET03599 0.306 0.03 DB06777 | DBMET03598 | |
| 0.292 | 0.019 | 0.384 | Amylase inhibitor | 0.384 0.01 DBMET03598 0.265 0.024 DBMET03599 0.292 0.019 DB06777 | DBMET03598 | |
| 0.271 | 0.001 | 0.405 | Vitamin D receptor agonist | 0.405 0 DBMET03598 0.347 0 DBMET03599 0.271 0.001 DB06777 | DBMET03598 | |
| 0.271 | 0 | 0.271 | Ileal bile acid transport inhibitor | 0.205 0.001 DBMET03598 0.155 0.001 DBMET03599 0.271 0 DB06777 | ||
| 0.27 | 0.003 | 0.27 | Botulinum neurotoxin type A inhibitor | 0.187 0.004 DBMET03598 0.158 0.004 DBMET03599 0.27 0.003 DB06777 | ||
| 0.284 | 0.02 | 0.284 | Insulin sensitizer | 0.272 0.024 DBMET03598 0.235 0.043 DBMET03599 0.284 0.02 DB06777 | ||
| 0.265 | 0.003 | 0.295 | Lanosterol 14 alpha demethylase inhibitor | 0.295 0.003 DBMET03598 0.211 0.004 DBMET03599 0.265 0.003 DB06777 | DBMET03598 | |
| 0.26 | 0.002 | 0.324 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.324 0.002 DBMET03598 0.317 0.002 DBMET03599 0.26 0.002 DB06777 | DBMET03598 | |
| 0.255 | 0.001 | 0.255 | Na+ K+ transporting ATPase inhibitor | 0.237 0.002 DBMET03598 0.243 0.001 DBMET03599 0.255 0.001 DB06777 | ||
| 0.271 | 0.019 | 0.284 | Interleukin 6 antagonist | 0.284 0.017 DBMET03598 0.246 0.024 DBMET03599 0.271 0.019 DB06777 | DBMET03598 | |
| 0.261 | 0.01 | 0.263 | Neurotrophic factor | 0.263 0.01 DBMET03598 0.2 0.027 DBMET03599 0.261 0.01 DB06777 | DBMET03598 | |
| 0.251 | 0.003 | 0.406 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.406 0.003 DBMET03598 0.355 0.003 DBMET03599 0.251 0.003 DB06777 | DBMET03598 | |
| 0.255 | 0.007 | 0.255 | Microtubule formation inhibitor | 0.251 0.008 DBMET03598 0.238 0.012 DBMET03599 0.255 0.007 DB06777 | ||
| 0.284 | 0.041 | 0.354 | EphB2 antagonist | 0.354 0.023 DBMET03598 0.24 0.062 DBMET03599 0.284 0.041 DB06777 | DBMET03598 | |
| 0.262 | 0.023 | 0.306 | Bone formation stimulant | 0.306 0.016 DBMET03598 0.277 0.02 DBMET03599 0.262 0.023 DB06777 | DBMET03598 | |
| 0.296 | 0.058 | 0.327 | Cardiotonic | 0.327 0.046 DBMET03598 0.304 0.054 DBMET03599 0.296 0.058 DB06777 | DBMET03598 | |
| 0.244 | 0.006 | 0.244 | Estrogen receptor alpha antagonist | 0.221 0.007 DBMET03598 0.141 0.013 DBMET03599 0.244 0.006 DB06777 | ||
| 0.235 | 0.002 | 0.258 | Anabolic | 0.245 0.002 DBMET03598 0.258 0.002 DBMET03599 0.235 0.002 DB06777 | DBMET03599 | |
| 0.234 | 0.003 | 0.26 | Glycine receptor antagonist | 0.26 0.002 DBMET03598 0.178 0.004 DBMET03599 0.234 0.003 DB06777 | DBMET03598 | |
| 0.23 | 0.003 | 0.243 | Carbonic anhydrase IV inhibitor | 0.175 0.004 DBMET03598 0.243 0.003 DBMET03599 0.23 0.003 DB06777 | DBMET03599 | |
| 0.231 | 0.004 | 0.231 | Progesterone antagonist | 0.213 0.004 DBMET03598 0.132 0.007 DBMET03599 0.231 0.004 DB06777 | ||
| 0.225 | 0.006 | 0.225 | Adenylate cyclase stimulant | 0.217 0.008 DBMET03598 0.205 0.011 DBMET03599 0.225 0.006 DB06777 | ||
| 0.272 | 0.054 | 0.296 | DNA synthesis inhibitor | 0.296 0.045 DBMET03598 0.232 0.081 DBMET03599 0.272 0.054 DB06777 | DBMET03598 | |
| 0.223 | 0.009 | 0.273 | Hedgehog signaling inhibitor | 0.273 0.005 DBMET03598 0.163 0.019 DBMET03599 0.223 0.009 DB06777 | DBMET03598 | |
| 0.213 | 0.003 | 0.276 | RNA-directed RNA polymerase stimulant | 0.276 0.002 DBMET03598 0.235 0.003 DBMET03599 0.213 0.003 DB06777 | DBMET03598 | |
| 0.218 | 0.009 | 0.218 | Antineoplastic alkaloid | 0.216 0.01 DBMET03598 0.186 0.018 DBMET03599 0.218 0.009 DB06777 | ||
| 0.205 | 0.008 | 0.255 | Prolactin inhibitor | 0.255 0.004 DBMET03598 0.167 0.016 DBMET03599 0.205 0.008 DB06777 | DBMET03598 | |
| 0.193 | 0.002 | 0.194 | Vitamin D receptor antagonist | 0.194 0.002 DBMET03598 0.171 0.002 DBMET03599 0.193 0.002 DB06777 | DBMET03598 | |
| 0.187 | 0.001 | 0.187 | Hedgehog signaling activator | 0.166 0.001 DBMET03598 0.093 0.001 DBMET03599 0.187 0.001 DB06777 | ||
| 0.256 | 0.072 | 0.256 | Tumour necrosis factor alpha release inhibitor | 0.21 0.1 DBMET03598 0.205 0.105 DBMET03599 0.256 0.072 DB06777 | ||
| 0.186 | 0.015 | 0.196 | Estrogen antagonist | 0.196 0.013 DBMET03598 0.155 0.021 DBMET03599 0.186 0.015 DB06777 | DBMET03598 | |
| 0.209 | 0.038 | 0.218 | Phospholipase A2 inhibitor | 0.218 0.034 DBMET03598 0.143 0.081 DBMET03599 0.209 0.038 DB06777 | DBMET03598 | |
| 0.179 | 0.009 | 0.24 | Estrogen agonist | 0.24 0.007 DBMET03598 0.162 0.01 DBMET03599 0.179 0.009 DB06777 | DBMET03598 | |
| 0.159 | 0.003 | 0.159 | Phospholipase D inhibitor | 0.15 0.003 DBMET03598 0.118 0.007 DBMET03599 0.159 0.003 DB06777 | ||
| 0.159 | 0.005 | 0.159 | CDC25B inhibitor | 0.157 0.005 DBMET03598 0.147 0.007 DBMET03599 0.159 0.005 DB06777 | ||
| 0.224 | 0.081 | 0.224 | Free radical scavenger | 0.216 0.085 DBMET03598 0.2 0.098 DBMET03599 0.224 0.081 DB06777 | ||
| 0.167 | 0.027 | 0.185 | Antineoplastic antibiotic | 0.151 0.031 DBMET03598 0.185 0.024 DBMET03599 0.167 0.027 DB06777 | DBMET03599 | |
| 0.235 | 0.097 | 0.257 | 5 Hydroxytryptamine uptake stimulant | 0.257 0.075 DBMET03598 0.219 0.119 DBMET03599 0.235 0.097 DB06777 | DBMET03598 | |
| 0.142 | 0.004 | 0.142 | Glucocorticoid antagonist | 0.112 0.004 DBMET03598 0.095 0.005 DBMET03599 0.142 0.004 DB06777 | ||
| 0.149 | 0.013 | 0.308 | Aromatase inhibitor | 0.186 0.009 DBMET03598 0.308 0.005 DBMET03599 0.149 0.013 DB06777 | DBMET03599 | |
| 0.163 | 0.03 | 0.275 | GABA receptor agonist | 0.275 0.008 DBMET03598 0.19 0.02 DBMET03599 0.163 0.03 DB06777 | DBMET03598 | |
| 0.145 | 0.017 | 0.145 | Transcription factor NF kappa B stimulant | 0.135 0.019 DBMET03598 0.125 0.023 DBMET03599 0.145 0.017 DB06777 | ||
| 0.135 | 0.009 | 0.135 | Autotaxin inhibitor | 0.074 0.021 DBMET03598 0.056 0.033 DBMET03599 0.135 0.009 DB06777 | ||
| 0.128 | 0.003 | 0.128 | Lipocortins synthesis agonist | 0.12 0.003 DBMET03598 0.112 0.004 DBMET03599 0.128 0.003 DB06777 | ||
| 0.132 | 0.008 | 0.132 | Caspase 9 inhibitor | 0.105 0.012 DBMET03598 0.093 0.016 DBMET03599 0.132 0.008 DB06777 | ||
| 0.195 | 0.075 | 0.214 | Non-steroidal antiinflammatory agent | 0.214 0.06 DBMET03598 0.183 0.085 DBMET03599 0.195 0.075 DB06777 | DBMET03598 | |
| 0.123 | 0.005 | 0.123 | Liver X receptor agonist | 0.121 0.006 DBMET03598 0.084 0.009 DBMET03599 0.123 0.005 DB06777 | ||
| 0.118 | 0.002 | 0.148 | Glucose-6-phosphate dehydrogenase inhibitor | 0.148 0.002 DBMET03598 0.122 0.002 DBMET03599 0.118 0.002 DB06777 | DBMET03598 | |
| 0.135 | 0.021 | 0.135 | Estrogen receptor beta antagonist | 0.134 0.021 DBMET03598 0.125 0.027 DBMET03599 0.135 0.021 DB06777 | ||
| 0.116 | 0.005 | 0.116 | Diacylglycerol O-acyltransferase inhibitor | 0.097 0.008 DBMET03598 0.064 0.023 DBMET03599 0.116 0.005 DB06777 | ||
| 0.168 | 0.057 | 0.241 | NOS3 expression enhancer | 0.241 0.029 DBMET03598 0.158 0.065 DBMET03599 0.168 0.057 DB06777 | DBMET03598 | |
| 0.119 | 0.01 | 0.119 | Phosphorylase inhibitor | 0.07 0.02 DBMET03598 0.119 0.01 DB06777 | ||
| 0.115 | 0.009 | 0.115 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.112 0.009 DBMET03598 0.092 0.013 DBMET03599 0.115 0.009 DB06777 | ||
| 0.108 | 0.003 | 0.11 | Parathyroid hormone antagonist | 0.11 0.003 DBMET03598 0.101 0.003 DBMET03599 0.108 0.003 DB06777 | DBMET03598 | |
| 0.107 | 0.004 | 0.159 | Heparanase inhibitor | 0.159 0.003 DBMET03598 0.092 0.004 DBMET03599 0.107 0.004 DB06777 | DBMET03598 | |
| 0.209 | 0.112 | 0.271 | Spasmolytic | 0.271 0.082 DBMET03598 0.226 0.102 DBMET03599 0.209 0.112 DB06777 | DBMET03598 | |
| 0.2 | 0.105 | 0.212 | Vasodilator | 0.212 0.095 DBMET03598 0.17 0.132 DBMET03599 0.2 0.105 DB06777 | DBMET03598 | |
| 0.159 | 0.07 | 0.182 | Melanin inhibitor | 0.171 0.058 DBMET03598 0.182 0.05 DBMET03599 0.159 0.07 DB06777 | DBMET03599 | |
| 0.112 | 0.024 | 0.169 | Keratolytic | 0.169 0.012 DBMET03598 0.107 0.027 DBMET03599 0.112 0.024 DB06777 | DBMET03598 | |
| 0.153 | 0.067 | 0.161 | Lipid peroxidase inhibitor | 0.161 0.061 DBMET03598 0.146 0.071 DBMET03599 0.153 0.067 DB06777 | DBMET03598 | |
| 0.138 | 0.053 | 0.154 | Adenylate cyclase inhibitor | 0.154 0.042 DBMET03598 0.129 0.06 DBMET03599 0.138 0.053 DB06777 | DBMET03598 | |
| 0.096 | 0.012 | 0.096 | Glutamate (mGluR6) antagonist | 0.089 0.016 DBMET03598 0.086 0.019 DBMET03599 0.096 0.012 DB06777 | ||
| 0.122 | 0.041 | 0.129 | Toll-Like receptor 4 antagonist | 0.129 0.035 DBMET03598 0.117 0.047 DBMET03599 0.122 0.041 DB06777 | DBMET03598 | |
| 0.084 | 0.003 | 0.084 | HMG CoA reductase inhibitor | 0.082 0.003 DBMET03598 0.079 0.004 DBMET03599 0.084 0.003 DB06777 | ||
| 0.088 | 0.008 | 0.092 | Acetyl-CoA transferase 2 inhibitor | 0.092 0.007 DBMET03598 0.082 0.01 DBMET03599 0.088 0.008 DB06777 | DBMET03598 | |
| 0.089 | 0.009 | 0.089 | Mineralocorticoid receptor antagonist | 0.088 0.009 DBMET03598 0.064 0.017 DBMET03599 0.089 0.009 DB06777 | ||
| 0.135 | 0.057 | 0.144 | Vanilloid 1 agonist | 0.144 0.044 DBMET03598 0.128 0.07 DBMET03599 0.135 0.057 DB06777 | DBMET03598 | |
| 0.09 | 0.016 | 0.095 | Prostaglandin F2 alpha antagonist | 0.095 0.013 DBMET03598 0.08 0.023 DBMET03599 0.09 0.016 DB06777 | DBMET03598 | |
| 0.132 | 0.057 | 0.148 | Cell adhesion inhibitor | 0.148 0.048 DBMET03598 0.104 0.081 DBMET03599 0.132 0.057 DB06777 | DBMET03598 | |
| 0.094 | 0.021 | 0.116 | GABA B receptor agonist | 0.116 0.009 DBMET03598 0.099 0.017 DBMET03599 0.094 0.021 DB06777 | DBMET03598 | |
| 0.174 | 0.102 | 0.181 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.181 0.092 DBMET03598 0.174 0.102 DB06777 | DBMET03598 | |
| 0.134 | 0.063 | 0.15 | Cyclooxygenase 3 inhibitor | 0.15 0.049 DBMET03598 0.121 0.076 DBMET03599 0.134 0.063 DB06777 | DBMET03598 | |
| 0.103 | 0.034 | 0.115 | Inducible nitric-oxide synthase inhibitor | 0.108 0.031 DBMET03598 0.115 0.027 DBMET03599 0.103 0.034 DB06777 | DBMET03599 | |
| 0.08 | 0.011 | 0.103 | Aldosterone antagonist | 0.103 0.008 DBMET03598 0.057 0.022 DBMET03599 0.08 0.011 DB06777 | DBMET03598 | |
| 0.085 | 0.018 | 0.085 | Nitric oxide donor | 0.08 0.023 DBMET03598 0.063 0.043 DBMET03599 0.085 0.018 DB06777 | ||
| 0.149 | 0.083 | 0.163 | Thrombolytic | 0.163 0.072 DBMET03598 0.149 0.083 DB06777 | DBMET03598 | |
| 0.096 | 0.031 | 0.112 | Estrogen-related receptor beta agonist | 0.112 0.014 DBMET03598 0.087 0.046 DBMET03599 0.096 0.031 DB06777 | DBMET03598 | |
| 0.079 | 0.014 | 0.108 | Estrogen receptor beta agonist | 0.108 0.01 DBMET03598 0.083 0.014 DBMET03599 0.079 0.014 DB06777 | DBMET03598 | |
| 0.169 | 0.105 | 0.17 | Interleukin antagonist | 0.17 0.103 DBMET03598 0.169 0.105 DB06777 | DBMET03598 | |
| 0.139 | 0.076 | 0.144 | Ca2+-transporting ATPase inhibitor | 0.144 0.061 DBMET03598 0.132 0.106 DBMET03599 0.139 0.076 DB06777 | DBMET03598 | |
| 0.116 | 0.053 | 0.132 | GABA C receptor agonist | 0.132 0.042 DBMET03598 0.087 0.083 DBMET03599 0.116 0.053 DB06777 | DBMET03598 | |
| 0.075 | 0.013 | 0.098 | Estrogen receptor alpha agonist | 0.098 0.009 DBMET03598 0.072 0.013 DBMET03599 0.075 0.013 DB06777 | DBMET03598 | |
| 0.063 | 0.004 | 0.067 | CYP24 inhibitor | 0.067 0.004 DBMET03598 0.059 0.004 DBMET03599 0.063 0.004 DB06777 | DBMET03598 | |
| 0.09 | 0.032 | 0.09 | Selectin antagonist | 0.07 0.042 DBMET03598 0.09 0.032 DB06777 | ||
| 0.067 | 0.009 | 0.125 | GABA B receptor antagonist | 0.125 0.004 DBMET03598 0.089 0.005 DBMET03599 0.067 0.009 DB06777 | DBMET03598 | |
| 0.061 | 0.004 | 0.061 | Ceramide glucosyltransferase inhibitor | 0.055 0.005 DBMET03598 0.039 0.018 DBMET03599 0.061 0.004 DB06777 | ||
| 0.101 | 0.044 | 0.117 | Ornithine decarboxylase inhibitor | 0.117 0.028 DBMET03598 0.105 0.039 DBMET03599 0.101 0.044 DB06777 | DBMET03598 | |
| 0.085 | 0.029 | 0.097 | HIV-1 integrase (Strand Transfer) inhibitor | 0.097 0.024 DBMET03598 0.082 0.03 DBMET03599 0.085 0.029 DB06777 | DBMET03598 | |
| 0.063 | 0.009 | 0.089 | GABA uptake inhibitor | 0.089 0.004 DBMET03598 0.046 0.019 DBMET03599 0.063 0.009 DB06777 | DBMET03598 | |
| 0.091 | 0.036 | 0.095 | T cell inhibitor | 0.095 0.029 DBMET03598 0.093 0.033 DBMET03599 0.091 0.036 DB06777 | DBMET03598 | |
| 0.074 | 0.02 | 0.076 | Heme oxygenase stimulant | 0.076 0.018 DBMET03598 0.075 0.019 DBMET03599 0.074 0.02 DB06777 | DBMET03598 | |
| 0.118 | 0.067 | 0.149 | Proteasome inhibitor | 0.149 0.047 DBMET03598 0.1 0.088 DBMET03599 0.118 0.067 DB06777 | DBMET03598 | |
| 0.064 | 0.012 | 0.081 | AICAR transformylase inhibitor | 0.081 0.007 DBMET03598 0.048 0.024 DBMET03599 0.064 0.012 DB06777 | DBMET03598 | |
| 0.062 | 0.012 | 0.062 | Microtubule stabilization | 0.06 0.014 DBMET03598 0.058 0.017 DBMET03599 0.062 0.012 DB06777 | ||
| 0.18 | 0.129 | 0.189 | Peptidyltransferase inhibitor | 0.189 0.114 DBMET03598 0.175 0.138 DBMET03599 0.18 0.129 DB06777 | DBMET03598 | |
| 0.072 | 0.025 | 0.188 | GABA receptor antagonist | 0.188 0.006 DBMET03598 0.154 0.009 DBMET03599 0.072 0.025 DB06777 | DBMET03598 | |
| 0.07 | 0.024 | 0.07 | Acetyl-CoA transferase inhibitor | 0.07 0.024 DBMET03598 0.053 0.037 DBMET03599 0.07 0.024 DB06777 | ||
| 0.053 | 0.01 | 0.091 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.091 0.005 DBMET03598 0.054 0.01 DBMET03599 0.053 0.01 DB06777 | DBMET03598 | |
| 0.064 | 0.023 | 0.077 | Pregnane X receptor antagonist | 0.077 0.008 DBMET03598 0.072 0.012 DBMET03599 0.064 0.023 DB06777 | DBMET03598 | |
| 0.051 | 0.011 | 0.065 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.065 0.006 DBMET03598 0.042 0.019 DBMET03599 0.051 0.011 DB06777 | DBMET03598 | |
| 0.044 | 0.004 | 0.044 | Corticosteroid-like | 0.039 0.004 DBMET03598 0.036 0.005 DBMET03599 0.044 0.004 DB06777 | ||
| 0.045 | 0.005 | 0.045 | Glucocorticoid agonist | 0.032 0.006 DBMET03598 0.024 0.007 DBMET03599 0.045 0.005 DB06777 | ||
| 0.098 | 0.058 | 0.107 | Interleukin 12 antagonist | 0.105 0.046 DBMET03598 0.107 0.044 DBMET03599 0.098 0.058 DB06777 | DBMET03599 | |
| 0.056 | 0.016 | 0.056 | Geranyltranstransferase inhibitor | 0.045 0.029 DBMET03598 0.04 0.038 DBMET03599 0.056 0.016 DB06777 | ||
| 0.042 | 0.005 | 0.042 | Prostaglandin F2 alpha agonist | 0.039 0.006 DBMET03598 0.031 0.008 DBMET03599 0.042 0.005 DB06777 | ||
| 0.068 | 0.031 | 0.07 | Carbonic anhydrase II inhibitor | 0.051 0.043 DBMET03598 0.07 0.029 DBMET03599 0.068 0.031 DB06777 | DBMET03599 | |
| 0.145 | 0.11 | 0.181 | ATPase inhibitor | 0.167 0.075 DBMET03598 0.181 0.056 DBMET03599 0.145 0.11 DB06777 | DBMET03599 | |
| 0.116 | 0.081 | 0.133 | Alpha-N-acetylglucosaminidase inhibitor | 0.133 0.067 DBMET03598 0.116 0.081 DB06777 | DBMET03598 | |
| 0.043 | 0.008 | 0.043 | Glutamate (mGluR3) agonist | 0.04 0.01 DBMET03598 0.038 0.011 DBMET03599 0.043 0.008 DB06777 | ||
| 0.042 | 0.011 | 0.045 | Prostaglandin D2 agonist | 0.044 0.01 DBMET03598 0.045 0.01 DBMET03599 0.042 0.011 DB06777 | DBMET03599 | |
| 0.031 | 0.003 | 0.031 | Thromboxane A2 agonist | 0.028 0.004 DBMET03598 0.021 0.005 DBMET03599 0.031 0.003 DB06777 | ||
| 0.105 | 0.078 | 0.121 | TRPA1 agonist | 0.121 0.057 DBMET03598 0.105 0.078 DB06777 | DBMET03598 | |
| 0.03 | 0.003 | 0.03 | Thromboxane agonist | 0.024 0.003 DBMET03598 0.016 0.004 DBMET03599 0.03 0.003 DB06777 | ||
| 0.06 | 0.035 | 0.063 | Carbonic anhydrase I inhibitor | 0.063 0.033 DBMET03599 0.06 0.035 DB06777 | DBMET03599 | |
| 0.047 | 0.026 | 0.069 | Opioid kappa receptor agonist | 0.051 0.023 DBMET03598 0.069 0.015 DBMET03599 0.047 0.026 DB06777 | DBMET03599 | |
| 0.055 | 0.035 | 0.139 | GABA A receptor antagonist | 0.139 0.01 DBMET03598 0.106 0.015 DBMET03599 0.055 0.035 DB06777 | DBMET03598 | |
| 0.025 | 0.004 | 0.025 | Telomerase stimulant | 0.023 0.005 DBMET03598 0.02 0.008 DBMET03599 0.025 0.004 DB06777 | ||
| 0.05 | 0.03 | 0.053 | Glucose-6-phosphate isomerase inhibitor | 0.053 0.025 DBMET03598 0.05 0.03 DB06777 | DBMET03598 | |
| 0.085 | 0.066 | 0.095 | Triose-phosphate isomerase inhibitor | 0.095 0.054 DBMET03598 0.081 0.074 DBMET03599 0.085 0.066 DB06777 | DBMET03598 | |
| 0.02 | 0.001 | 0.028 | Transcortin receptor antagonist | 0.023 0.001 DBMET03598 0.028 0.001 DBMET03599 0.02 0.001 DB06777 | DBMET03599 | |
| 0.026 | 0.008 | 0.036 | Progesterone agonist | 0.036 0.006 DBMET03598 0.027 0.008 DBMET03599 0.026 0.008 DB06777 | DBMET03598 | |
| 0.067 | 0.05 | 0.078 | Phosphofructokinase-1 inhibitor | 0.078 0.042 DBMET03598 0.067 0.05 DB06777 | DBMET03598 | |
| 0.054 | 0.036 | 0.058 | Protein 50S ribosomal subunit inhibitor | 0.056 0.034 DBMET03598 0.058 0.032 DBMET03599 0.054 0.036 DB06777 | DBMET03599 | |
| 0.035 | 0.018 | 0.039 | Carboxypeptidase B inhibitor | 0.039 0.014 DBMET03598 0.035 0.018 DB06777 | DBMET03598 | |
| 0.098 | 0.081 | 0.098 | Chelator | 0.098 0.081 DB06777 | ||
| 0.02 | 0.003 | 0.021 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.021 0.003 DBMET03598 0.019 0.003 DBMET03599 0.02 0.003 DB06777 | DBMET03598 | |
| 0.039 | 0.022 | 0.039 | Glutamate (mGluR3) antagonist | 0.036 0.026 DBMET03598 0.039 0.022 DB06777 | ||
| 0.024 | 0.007 | 0.024 | Prostacyclin agonist | 0.024 0.007 DBMET03598 0.018 0.01 DBMET03599 0.024 0.007 DB06777 | ||
| 0.061 | 0.045 | 0.063 | Carbonic anhydrase inhibitor | 0.063 0.044 DBMET03599 0.061 0.045 DB06777 | DBMET03599 | |
| 0.034 | 0.018 | 0.034 | Prostaglandin agonist | 0.03 0.023 DBMET03598 0.028 0.025 DBMET03599 0.034 0.018 DB06777 | ||
| 0.08 | 0.064 | 0.126 | GABA A receptor agonist | 0.126 0.022 DBMET03598 0.089 0.049 DBMET03599 0.08 0.064 DB06777 | DBMET03598 | |
| 0.036 | 0.021 | 0.037 | Tubulin agonist | 0.037 0.019 DBMET03598 0.037 0.019 DBMET03599 0.036 0.021 DB06777 | DBMET03599 | |
| 0.059 | 0.044 | 0.066 | Carbamoyl phosphate synthetase inhibitor | 0.066 0.037 DBMET03598 0.059 0.044 DB06777 | DBMET03598 | |
| 0.021 | 0.007 | 0.021 | Thyroid hormone alpha antagonist | 0.015 0.012 DBMET03598 0.021 0.007 DB06777 | ||
| 0.033 | 0.02 | 0.038 | ATP citrate lysase inhibitor | 0.038 0.015 DBMET03598 0.032 0.022 DBMET03599 0.033 0.02 DB06777 | DBMET03598 | |
| 0.043 | 0.037 | 0.043 | Antimetabolite | 0.043 0.037 DB06777 | ||
| 0.008 | 0.002 | 0.009 | Vitamin D-like | 0.009 0.002 DBMET03598 0.007 0.002 DBMET03599 0.008 0.002 DB06777 | DBMET03598 | |
| 0.031 | 0.027 | 0.04 | Liver X receptor beta agonist | 0.04 0.015 DBMET03598 0.031 0.027 DB06777 | DBMET03598 | |
| 0.021 | 0.017 | 0.021 | Prostaglandin EP2 agonist | 0.021 0.017 DB06777 | ||
| 0.037 | 0.035 | 0.037 | Acetyl-CoA transferase 1 inhibitor | 0.037 0.034 DBMET03598 0.037 0.035 DB06777 | ||
| 0.028 | 0.027 | 0.037 | Cholesterol ester transfer protein antagonist | 0.037 0.016 DBMET03598 0.029 0.025 DBMET03599 0.028 0.027 DB06777 | DBMET03598 | |
| 0.041 | 0.041 | 0.05 | Potassium channel Kv1.3 blocker | 0.05 0.029 DBMET03598 | DBMET03598 | |
| 0.019 | 0.019 | 0.042 | Estrone sulfatase inhibitor | 0.042 0.009 DBMET03598 | DBMET03598 | |
| 0.026 | 0.028 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 DBMET03598 | DBMET03598 | |
| 0.078 | 0.082 | 0.083 | ATPase (Vacuolar H+) inhibitor | 0.083 0.071 DBMET03598 | DBMET03598 | |
| 0.088 | 0.092 | 0.095 | Adenylate kinase inhibitor | 0.095 0.075 DBMET03598 | DBMET03598 | |
| 0.129 | 0.137 | 0.202 | Psychostimulant | 0.202 0.079 DBMET03598 | DBMET03598 | |
| 0.031 | 0.042 | 0.063 | Estradiol 17 beta-dehydrogenase inhibitor | 0.063 0.018 DBMET03598 0.045 0.027 DBMET03599 | DBMET03598 | |
| 0.092 | 0.105 | 0.102 | Photosensitizer | 0.102 0.084 DBMET03598 | DBMET03598 | |
| 0.074 | 0.091 | 0.078 | Vanilloid agonist | 0.078 0.076 DBMET03598 | DBMET03598 | |
| 0.079 | 0.096 | 0.086 | Glutamate release inhibitor | 0.086 0.072 DBMET03598 | DBMET03598 | |
| 0.073 | 0.096 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.077 DBMET03598 | DBMET03598 | |
| 0.02 | 0.054 | 0.038 | Nicotinic acid receptor agonist | 0.038 0.023 DBMET03598 | DBMET03598 | |
| 0.039 | 0.081 | 0.059 | NMDA 2C receptor antagonist | 0.059 0.046 DBMET03598 | DBMET03598 | |
| 0.074 | 0.121 | 0.118 | Anesthetic local | 0.118 0.069 DBMET03598 0.095 0.087 DBMET03599 | DBMET03598 | |
| 0.122 | 0.171 | 0.224 | Aldehyde oxidase inhibitor | 0.224 0.093 DBMET03598 | DBMET03598 | |
| 0.052 | 0.108 | 0.079 | Acetylcholine nicotinic antagonist | 0.079 0.055 DBMET03598 | DBMET03598 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |